Which stages does Pureos Bioventures invest in?

Pureos Bioventures invests at Series A, Series B and Seed.

Where is Pureos Bioventures based?

Pureos Bioventures is headquartered in Schwyz, Switzerland.

Investor directory

Pureos Bioventures

VC fundSchwyz, Switzerlandpureosbio.com LinkedIn

Pureos Bioventures invests in innovative drug development companies with a focus on next-generation biological drugs.

What they invest in

Stages

Series A Series B Seed

Sectors

Biotech & Pharma HealthTech

Geographies

Europe

The facts

Headquarters: Schwyz, Switzerland

Portfolio companies

ADCytherix Alentis Therapeutics AnaCardio Citryll -Novago Therapeutics

More portfolio companies

AM-PharmaLava TherapeuticsVico TherapeuticsAriceumMediar TherapeuticsAcrivon Therapeutics (NAS: ACRV)ImCheck TherapeuticsTavo BiotherapeuticsMemo TherapeuticsPulseSight TherapeuticsRiver 3 RenalArarisAcrivon TherapeuticsAM PharmaAraris BiotechCallio TherapeuticsCorlieve TherapeuticsEngimmune TherapeuticsEvidence BioHummingbird Bioscience

Recent rounds

Citryll
€85MSeries BHealthTech
Forbionlead Novartis Venture FundleadPureos BioventuresDe Brabantse Ontwikkelings Maatschappij BioGeneration Ventures Seventure Partners · +3 more in the source
10 December 2024Netherlandssiliconcanals.com

Rounds Pureos Bioventures took part in, as reported by the linked articles. See who else is investing right now.

Questions founders ask

Which stages does Pureos Bioventures invest in?: Pureos Bioventures invests at Series A, Series B and Seed.
Where is Pureos Bioventures based?: Pureos Bioventures is headquartered in Schwyz, Switzerland.

Does Pureos Bioventures fit your round?

In 30 minutes you'll know which funds matter for your round.

Get a demo

Search investors like this in Claude — no account, no sign-in. Open in Claude

Are you Pureos Bioventures? Tell us what to correct and we will update it — or ask us to remove the entry.